This event has been cancelled. You are welcome to book the webinar version of this event by clicking here. You can watch webinars anywhere with a good internet connection.
Join us to understand how critically important the genetic and epigenetic changes in cancer are for disease biology and novel treatments.
Learning objectives include:
This meeting will be relevant to clinical and medical oncologists, geneticists, basic scientists interested in cancer biology and genetics (cancer researchers), radiologist, pathologists, pharmacists, cancer researchers and cancer nurses, medical students and trainees interested in cancer and genetics.
There are 30 free bursary places available on a first come, first served basis. To claim your free place, please email us at oncology@rsm.ac.uk.
Join in the conversation online
Follow us on Twitter: @RoySocMed
E. Dixon Heise Distinguished Professor in Oncology, University of California San Francisco, President, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, Senior Vice President for Cancer Services, University of California San Francisco Health, Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, United States of America
Professor of Gynaecological Cancer, University of Melbourne, Joint Head, Clinical Translation Centre, Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Medical Oncologist, Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women's Hospitals, Australia
Director, Cancer Research UK Edinburgh Centre, Charles and Ethel Barr Chair of Cancer Research
Chair: Professor Michael Seckl, Immediate Past President, Oncology Section, Royal Society of Medicine and Dr Susana Banerjee, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Reader in Women’s Cancers, Institute of Cancer Research
Delivered virtually by Professor Alan Ashworth, President, Helen Diller Family Comprehensive Cancer Center at University of California, San Francisco and Senior Vice President for Clinical Services, University of California San Francisco Health, United States of America
Delivered virtually by Professor Clare Scott, Professor of Gynaecological Cancer, University of Melbourne, Joint Head, Clinical Translation Centre, Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Medical Oncologist, Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women's Hospitals, Australia
Dr Susana Banerjee
Chair: Professor Chrissie Thirlwell, Mireille Gillings Professor of Cancer Genomics, University of Exeter Medical School and Dr Sarah Rae, President, Medical Genetics Section, Royal Society of Medicine
Professor Idriss Bennani-Baiti, President and Chief Executive Officer, Cancer Epigenetics Society, Austria
Professor Chrissie Thirlwell
Professor Robert Brown, Senior Research Investigator. Imperial College London
Chair: Professor Christopher Nutting, President, Oncology Section, Royal Society of Medicine
Dr James Kinross, Senior Lecturer in Surgery, Imperial College London
Professor Eric Aboagye, Professor of Cancer Pharmacology & Molecular Imaging, Imperial College London
Dr Claire Roddie, Consultant Haematologist, University College London Hospitals NHS Foundation Trust, Honorary Senior Lecturer in Haematology, University College London
Chair: Professor Christopher Nutting, Dr Sarah Rae and Professor Michael Seckl
Professor Fiona Blackhall, Professor of Thoracic Oncology, Honorary Consultant in Medical Oncology, The University of Manchester, The Christie NHS Foundation Trust, Manchester
Professor Ian Tomlinson, Director, Cancer Research UK Edinburgh Centre, Charles and Ethel Barr Chair of Cancer Research
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
